Skip to content

Drug interactions

Lumefantrine + Paroxetine

Severity: Major

Lumefantrine and Paroxetine: major interaction.

Last updated Sources: UK SmPC

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lumefantrine inhibits CYP2D6 and can raise paroxetine levels, and both drugs can prolong the QTc interval. The combination increases the risk of QT-related arrhythmia.

What this interaction means in plain words

Lumefantrine and Paroxetine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

CYP2D6 inhibition by lumefantrine and additive QTc prolongation.

What to do

Obtain a baseline ECG and correct potassium and magnesium abnormalities. Avoid the combination in patients with other QT risk factors or consider an alternative antimalarial.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lumefantrine and Paroxetine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Lumefantrine with Paroxetine?

MediHelp rates the interaction as major. Lumefantrine and Paroxetine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Lumefantrine inhibits CYP2D6 and can raise paroxetine levels, and both drugs can prolong the QTc interval. The combination increases the risk of QT-related arrhythmia.

How serious is the interaction between Lumefantrine and Paroxetine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and correct potassium and magnesium abnormalities. Avoid the combination in patients with other QT risk factors or consider an alternative antimalarial.

What other medicines interact with Paroxetine?

MediHelp also lists interactions of Paroxetine with, for example, Isocarboxazid, Methylene blue, Phenelzine. The full list is on the Paroxetine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in